Literature DB >> 31969399

Overcoming the health system barriers to early diagnosis and management of multidrug-resistant tuberculosis in a rural setting in North India.

Mohammad Abu Bashar1, Arun Aggarwal2, Sudip Bhattacharya3.   

Abstract

India contributes a quarter of the global burden of multidrug-resistant tuberculosis (MDR-TB) and has inadequate diagnostic infrastructure and institutional capacities for drug susceptibility testing. Subsequently, this leads to a large number of undetected and untreated cases of MDR-TB. In this report, we describe a case of a 55-year-old man from rural North India presenting with complaints of continued symptoms of chronic cough, fever and dyspnoea despite being recently diagnosed with recurrent tuberculosis and receiving treatment from the local community health centre. MDR-TB was suspected, but confirmatory diagnostic capabilities were not available in the local setting. The patient was finally diagnosed with MDR-TB. Treatment was coordinated by the district tuberculosis programme officer. Through this case, we describe the various barriers to detecting MDR-TB in the rural regions of India. Prompt identification of patients with presumptive MDR-TB, diagnosis of the disease and initiation of treatment are crucial to preventing disease transmission and reducing morbidity and mortality. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  global health; tuberculosis

Mesh:

Substances:

Year:  2020        PMID: 31969399      PMCID: PMC7021120          DOI: 10.1136/bcr-2019-231009

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Using a bus service for transporting sputum specimens to the Central Reference Laboratory: effect on the routine TB culture service in Malawi.

Authors:  A D Harries; J Michongwe; T E Nyirenda; J R Kemp; S B Squire; A R Ramsay; P Godfrey-Faussett; F M Salaniponi
Journal:  Int J Tuberc Lung Dis       Date:  2004-02       Impact factor: 2.373

2.  Are sputum samples of retreatment tuberculosis reaching the reference laboratories? A 9-year audit in Tanzania.

Authors:  A M Kilale; B J Ngowi; G S Mfinanga; S Egwaga; B Doulla; A M V Kumar; M Khogali; J van Griensven; A D Harries; R Zachariah; S G Hinderaker
Journal:  Public Health Action       Date:  2013-06-21

3.  Why are tuberculosis patients not treated earlier? A study of informal health practitioners in Bangladesh.

Authors:  M Rifat; I D Rusen; Md A Islam; D A Enarson; F Ahmed; S M Ahmed; F Karim
Journal:  Int J Tuberc Lung Dis       Date:  2011-05       Impact factor: 2.373

4.  Performance of culture and drug susceptibility testing in pulmonary tuberculosis patients in northern China.

Authors:  W Qi; A D Harries; S G Hinderaker
Journal:  Int J Tuberc Lung Dis       Date:  2011-01       Impact factor: 2.373

5.  MDR-TB screening in a setting with molecular diagnostic techniques: who got tested, who didn't and why?

Authors:  H D Shewade; S Govindarajan; B N Sharath; J P Tripathy; P Chinnakali; A M V Kumar; M Muthaiah; K Vivekananda; A K Paulraj; G Roy
Journal:  Public Health Action       Date:  2015-06-21

6.  Management of previously treated tuberculosis patients in Kalutara district, Sri Lanka: how are we faring?

Authors:  S C Abeygunawardena; B N Sharath; R Van den Bergh; B Naik; N Pallewatte; M N N Masaima
Journal:  Public Health Action       Date:  2014-06-21

7.  Operational challenges in diagnosing multi-drug resistant TB and initiating treatment in Andhra Pradesh, India.

Authors:  Sarabjit S Chadha; B N Sharath; Kishore Reddy; Jyothi Jaju; P H Vishnu; Sreenivas Rao; Malik Parmar; Srinath Satyanarayana; Kuldeep Singh Sachdeva; Nevin Wilson; Anthony D Harries
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

Review 8.  Time to treatment for rifampicin-resistant tuberculosis: systematic review and meta-analysis.

Authors:  R Boyd; N Ford; P Padgen; H Cox
Journal:  Int J Tuberc Lung Dis       Date:  2017-11-01       Impact factor: 2.373

9.  High pre-diagnosis attrition among patients with presumptive MDR-TB: an operational research from Bhopal district, India.

Authors:  Hemant Deepak Shewade; Arun M Kokane; Akash Ranjan Singh; Manoj Verma; Malik Parmar; Ashish Chauhan; Sanjay Singh Chahar; Manoj Tiwari; Sheeba Naz Khan; Vivek Gupta; Jaya Prasad Tripathy; Mukesh Nagar; Sanjai Kumar Singh; Pradeep Kumar Mehra; Ajay Mv Kumar
Journal:  BMC Health Serv Res       Date:  2017-04-04       Impact factor: 2.655

10.  Low pre-diagnosis attrition but high pre-treatment attrition among patients with MDR-TB: An operational research from Chennai, India.

Authors:  Hemant Deepak Shewade; Dina Nair; Joel S Klinton; Malik Parmar; J Lavanya; Lakshmi Murali; Vivek Gupta; Jaya Prasad Tripathy; Soumya Swaminathan; Ajay M V Kumar
Journal:  J Epidemiol Glob Health       Date:  2017-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.